business ⚖️ High Court questions FDA's quick drug license cancellation
The Bombay High Court pulled up the Maharashtra FDA over its 'high-handed' cancellation of Cipla's drug sale licenses. The court questioned the hasty conduct of the FDA in issuing the order against Cipla Pharma & Life Sciences Limited. This action was brought up in the case of Cipla Pharma and Life Sciences v. State of Maharashtra & Ors. The decision was challenged by Cipla against the actions taken by the state body. Consequently, the Maharashtra FDA agreed to withdraw its previous order after judicial scrutiny. ⚖️